Atlas Trials

Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis

Clinical trial NCT05165160 · COMPLETED

Trial details

NCT number
NCT05165160
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Nsclc
Start date
2022-02-15
Primary completion
2025-04-02
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.